William Marsh Rice University   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Houston TX United States (1912)

Organization Overview

First Clinical Trial
2010
NCT01384708
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

William Marsh Rice University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 1)

Barrett Esophagus (Phase 1)

Carcinoma, Squamous Cell (Phase 1)

Eclampsia (Phase 2)

Esophageal Squamous Cell Carcinoma (Phase 1)

Genital Neoplasms, Female (Phase 1)

Leukemia (Phase 1)

Leukemia, Myeloid (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Neoplasms (Phase 2)

Neoplasms, Squamous Cell (Phase 1)

Pre-Eclampsia (Phase 2)

Stomach Neoplasms (Phase 1)

Uterine Cervical Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 11
  • # of Trial APIs: 8